Association between the angiotensinogen 235T-variant and essential hypertension in whites: A systematic review and methodological appraisal

Hypertension

Volumn 30, Issue 6, 1997, Pages 1331-1337

  Kunz, Regina ^b   Kreutz, Reinhold ^b   Beige, Joachim ^b   Distler, Armin ^b   Sharma, Arya M ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b NONE

Author keywords

Angiotensinogen; Genetics; Meta analysis humans

Indexed keywords

ANGIOTENSINOGEN;

ALLELE; ARTICLE; CAUCASIAN; ESSENTIAL HYPERTENSION; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM;

EID: 0030696254     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.6.1331     Document Type: Article

References (36)

1. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press; 1990:81-100.
2. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265:2037-2048.
3. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
4. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription. J Clin Invest. 1997;99:1786-1797.
5. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJ. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994;330:1629-1633.
6. Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, Lawson M, De Freitas P, Fogarty P, Clark AJL. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest. 1995;96:687-692.
7. Schmidt S, Sharma AM, Zilch O, Beige J, Walla Friedel M, Ganten D, Distler A, Ritz E. Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant. 1995;10:1145-1148.
8. Bennett CL, Schrader AP, Morris BJ. Cross-sectional analysis of Met235->Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun. 1993;197:833-839.
9. Fornage M, Turner ST, Sing CF, Boerwinkle E. Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota. Hum Genet. 1995;96:295-300.
10. Hingorani AD, Sharma P, Haiyan J, Hopper R, Brown MJ. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension. 1996;28:907-911.
11. Kamitani R, Rakugi H, Hikagi J, Yi Z, Mikami H, Miki T, Ogihara T. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens. 1994;8:521-524.
12. 235->Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations. J Hypertens. 1995;13:717-722.
13. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel J-M. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest. 1994;93:1285-1287.
14. Rotimi C, Puras A, Cooper R, McFarlane-Anderson N, Forrester T, Ogunbiyi O, Morrison L, Ward R. Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension. 1996;27:558-563.
15. Rotimi C, Morrison L, Cooper R, Oyejide C, Effiong E, Ladipo M, Osotemihen B, Ward R. Angiotensinogen gene in human hypertension: lack of an association of the 235T allele among African Americans. Hypertension. 1994;24:591-594.
16. Jeunemaitre X, Charru A, Chatellier G, Dumont C, Sassano P, Soubrier F, Ménard J, Corvol P. M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens. 1993;11(suppl 5):S80-S81.
17. Johnson AG, Simons LA, Friedlander Y, Simons J, Davis DR, MaCallum J. M235→T polymorphism of the angiotensinogen gene predicts hypertension in the elderly. J Hypertens. 1996;14: 1061-1065.
18. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M, Sharma AM, Gimenez-Roqueplo A-P, Hata A, Corvol P, Lalouel J-M. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet. 1997;60:1448-1460.
19. Kiema T-R, Kauma H, Rantala AO, Lilja M, Reunanen A, Kesäniemi YA, Savolainen MJ. Variation at the angiotensin-converting-enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension. 1996;28:1070-1075.
20. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou J-P, Luc G, Evans A, Nicaud V, Cambien F. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM study. J Hypertens. 1995;13:311-317.
21. Mantel N, Haenzsel W. Statistical aspects of the analysis of data from retrospective studies of the disease. J Natl Cancer Inst. 1959; 22:719-748.
22. Breslow NE, Day NE. The analysis of case-control studies. In: Statistical Analysis in Cancer Research. Lyon, France. IARC Scientific Publication No 32, 1980.
23. Bloem LJ, Manatung AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest. 1995;95:948-953.
24. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S, Berrebi S, Sasaki M, Corvol P, Lifton RP, Lalouel J-M. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet. 1993;4: 59-61.
25. Schunkert H, Hense HW, Gimenez-Roqueplo AP, Stieber J, Keil U, Riegger GAJ, Jeunemaitre X. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort. Hypertension. 1997;29:628-633.
26. Fleiss JL, Gross AJ. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer. J Clin Epidemiol. 1991; 44:127-139.
27. Hodge SE. Cosegregation, association, and linkage. Am J Hum Genet. 1994;54:560-563.
28. Morris BJ. Identification of essential hypertension genes. J Hypertens. 1993;11:115-120.
29. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA. 1990;263:1385-1389.
30. Rosenthal R. Combining the results of independent studies. Psych Bull. 1978;85:185-193.
31. Re RN, Frohlich ED. Controversies in the genetic analysis of hypertensive diseases. Hypertension. 1996;28:880.
32. Hodge SE. Linkage analysis versus association analysis: distinguishing between two models that explain disease-marker associations. Am J Hum Genet. 1993;53:367-384.
33. Khoury M, James LM. Population and familial relative risks of disease with environmental factors in the presence of gene-environment interaction. Am J Epidemiol. 1993;137:1241-1250.
34. Thomson G. Mapping disease genes: family based association studies. Am J Hum Genet. 1995;57:487-498.
35. Falk CT, Rubinstein P. Haplotype relative risks: an easy way to construct a proper control sample for risk calculations. Ann Hum Genet. 1987:51:227-233.
36. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516-1517.